Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
9.46
-0.18 (-1.87%)
Jul 18, 2025, 4:00 PM - Market closed
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2.46 billion as of July 18, 2025. Its market cap has decreased by -52.47% in one year.
Market Cap
2.46B
Enterprise Value
10.87B
1-Year Change
-52.47%
Ranking
Category
Stock Price
$9.46
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.46B, a decrease of -70.78%. That is a compound annual growth rate of -25.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 2.46B | -36.00% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |